Essex Bio-Technology (HKG:1061) reported a profit of HK$157.4 million in the first half ended June 30, down 7.3% from HK$169.8 million in the prior-year period, according to a Monday filing with the Hong Kong stock exchange.
Earnings per share was HK$0.269, also down from HK$0.288 in the year-ago period.
The company's revenue fell 9.8% to HK$811.6 million from HK$899.4 million last year.
The board declared an interim dividend of HK$0.06 per share, up from HK$0.045 a year prior.
Price (HKD): $2.30, Change: $-0.080, Percent Change: -3.36%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments